Market Cap 10.43M
Revenue (ttm) 0.00
Net Income (ttm) -11.62M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio -0.16
Volume 422,200
Avg Vol 1,555,664
Day's Range N/A - N/A
Shares Out 9.84M
Stochastic %K 13%
Beta 0.24
Analysts Strong Sell
Price Target $7.50

Company Profile

Brainstorm Cell Therapeutics Inc. a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company's NurOwn proprietary cell therapy platform that leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival, and enhance...

Industry: Biotechnology
Sector: Healthcare
Phone: 201 488 0460
Address:
1325 Avenue of Americas, 28th Floor, New York, United States
thres
thres Jun. 29 at 5:31 AM
$BCLI "Trials take years years most ALS patients simply don't have... this is not an acne medicine or a lotion this is something to save our lives for years Patty Manhart has been fighting for any drug that could extend her life with ALS she has to fight for maybe treatment of Neuron it the one drug that has given Patty hope For some ALS patients it's reversed ALS symptoms this former Navy pilot Matt Bellina was able to stand on his own again despite powerful testimony in front of an FDA committee where patients talked about regaining their ability to move and breathe on their own only one member of the 19 member committee voted to support granting access to the drug The ALS community didn't all expect that we would have the same results as Matt and be able to get up out of our wheelchair but we hope for at least a longer life' now I will see my friends die and they will see me die. (She died Waiting - A true ALS Warrior RIP) https://www.youtube.com/watch?v=S4HpKJjlgQ8
0 · Reply
thres
thres Jun. 29 at 12:06 AM
$BCLI Nurown works and should be FDA approved, ALS patients say only good things about Nurown, Sep 2023 AdCom was Kangaroo Court and Nurown should have been approved. FB Post by ALS News Today Three years after its approval in the U.S., Radicava ORS has been prescribed to more than 13,500 ALS patients Patient Comments: David Useless drug! Robert Yeah it’s been 3 years since nothing happened new or better from ours pharmaceutical industry. Susan $150,000 a year! My husband saw no benefit and went off. Sharon My husbands neurologist said it doesn’t have proof of working and that he would not take it if it was him so husband off now after over a year Jane E. It made me feel worse, I stopped taking it. Jane E. My son called and canceled my Ridacava for me and they continue to call and leave me messages, I have very good insurance and they want that money. They don’t care about me. Vesna Jane E. my husband has same experience and he stopped it too. https://alsnewstoday.com/news/thousands-us-use-als-treatment-radicava-ors-company-says/
0 · Reply
Dakota1961
Dakota1961 Jun. 27 at 9:10 PM
$BCLI Luna was looking at her crystal ball, and she is predicting some time before market open Monday, this will blast off. Luna is one smart dog.
1 · Reply
Igmon007
Igmon007 Jun. 27 at 8:56 PM
$BCLI With $3.3M in the bank after the resale of those shares they can fully start the trial. Next week I'm looking for a PR regarding an extension from Nas and the start of the trial.
0 · Reply
Pipemajors82
Pipemajors82 Jun. 27 at 8:12 PM
$BCLI so does trial start Monday ? No registration? No announcement. HTF do you run a company like this ?
4 · Reply
HUMBL4Now
HUMBL4Now Jun. 27 at 8:02 PM
$BCLI wow nothing of course
0 · Reply
Mobagri
Mobagri Jun. 27 at 5:13 PM
$BCLI stockholders should sue this company for repeatedly misleading them. Where is the fake trial?
1 · Reply
HUMBL4Now
HUMBL4Now Jun. 26 at 9:40 PM
$BCLI PR tmw about enrollment opening or FDA approval, or this is definitely delisted….
2 · Reply
Cellsci
Cellsci Jun. 26 at 8:29 PM
$BCLI https://www.marketscreener.com/quote/stock/BRAINSTORM-CELL-THERAPEUT-18118014/news/Brainstorm-Cell-Therapeutics-Files-for-Resale-of-2-76-Million-Shares-by-Investor-50336163/?utm_source=copy&utm_medium=social&utm_campaign=share. Found this?
0 · Reply
ripztrip
ripztrip Jun. 26 at 8:22 PM
$BCLI Not seeing any filings or news about any funding. That's been the past 4-5 messages. What is this about exactly? Any links?
0 · Reply
Latest News on BCLI
BrainStorm Issues 2024 Letter to Shareholders

Dec 30, 2024, 8:00 AM EST - 6 months ago

BrainStorm Issues 2024 Letter to Shareholders


thres
thres Jun. 29 at 5:31 AM
$BCLI "Trials take years years most ALS patients simply don't have... this is not an acne medicine or a lotion this is something to save our lives for years Patty Manhart has been fighting for any drug that could extend her life with ALS she has to fight for maybe treatment of Neuron it the one drug that has given Patty hope For some ALS patients it's reversed ALS symptoms this former Navy pilot Matt Bellina was able to stand on his own again despite powerful testimony in front of an FDA committee where patients talked about regaining their ability to move and breathe on their own only one member of the 19 member committee voted to support granting access to the drug The ALS community didn't all expect that we would have the same results as Matt and be able to get up out of our wheelchair but we hope for at least a longer life' now I will see my friends die and they will see me die. (She died Waiting - A true ALS Warrior RIP) https://www.youtube.com/watch?v=S4HpKJjlgQ8
0 · Reply
thres
thres Jun. 29 at 12:06 AM
$BCLI Nurown works and should be FDA approved, ALS patients say only good things about Nurown, Sep 2023 AdCom was Kangaroo Court and Nurown should have been approved. FB Post by ALS News Today Three years after its approval in the U.S., Radicava ORS has been prescribed to more than 13,500 ALS patients Patient Comments: David Useless drug! Robert Yeah it’s been 3 years since nothing happened new or better from ours pharmaceutical industry. Susan $150,000 a year! My husband saw no benefit and went off. Sharon My husbands neurologist said it doesn’t have proof of working and that he would not take it if it was him so husband off now after over a year Jane E. It made me feel worse, I stopped taking it. Jane E. My son called and canceled my Ridacava for me and they continue to call and leave me messages, I have very good insurance and they want that money. They don’t care about me. Vesna Jane E. my husband has same experience and he stopped it too. https://alsnewstoday.com/news/thousands-us-use-als-treatment-radicava-ors-company-says/
0 · Reply
Dakota1961
Dakota1961 Jun. 27 at 9:10 PM
$BCLI Luna was looking at her crystal ball, and she is predicting some time before market open Monday, this will blast off. Luna is one smart dog.
1 · Reply
Igmon007
Igmon007 Jun. 27 at 8:56 PM
$BCLI With $3.3M in the bank after the resale of those shares they can fully start the trial. Next week I'm looking for a PR regarding an extension from Nas and the start of the trial.
0 · Reply
Pipemajors82
Pipemajors82 Jun. 27 at 8:12 PM
$BCLI so does trial start Monday ? No registration? No announcement. HTF do you run a company like this ?
4 · Reply
HUMBL4Now
HUMBL4Now Jun. 27 at 8:02 PM
$BCLI wow nothing of course
0 · Reply
Mobagri
Mobagri Jun. 27 at 5:13 PM
$BCLI stockholders should sue this company for repeatedly misleading them. Where is the fake trial?
1 · Reply
HUMBL4Now
HUMBL4Now Jun. 26 at 9:40 PM
$BCLI PR tmw about enrollment opening or FDA approval, or this is definitely delisted….
2 · Reply
Cellsci
Cellsci Jun. 26 at 8:29 PM
$BCLI https://www.marketscreener.com/quote/stock/BRAINSTORM-CELL-THERAPEUT-18118014/news/Brainstorm-Cell-Therapeutics-Files-for-Resale-of-2-76-Million-Shares-by-Investor-50336163/?utm_source=copy&utm_medium=social&utm_campaign=share. Found this?
0 · Reply
ripztrip
ripztrip Jun. 26 at 8:22 PM
$BCLI Not seeing any filings or news about any funding. That's been the past 4-5 messages. What is this about exactly? Any links?
0 · Reply
MichaelBW
MichaelBW Jun. 26 at 8:09 PM
$BCLI Correction 2.76 million.
2 · Reply
MichaelBW
MichaelBW Jun. 26 at 7:59 PM
$BCLI. IBKR had an AI generated read about the stockholders meeting. Takeaway was..2million new shares approved. Lol..I wish I sold last Friday. Had..22k share..no mas.
0 · Reply
whistleblower7
whistleblower7 Jun. 26 at 12:43 PM
$BCLI DID ANYONE LISTEN TO THE SHAREHOLDER MEETING? DID THEY DISCUSS WHEN THE TRAIL WAS GOING TO GET STARTED?HELP
2 · Reply
HUMBL4Now
HUMBL4Now Jun. 26 at 11:56 AM
$BCLI still nothing!
1 · Reply
Igmon007
Igmon007 Jun. 25 at 9:49 PM
$BCLI This might be the bridge $$ needed to get the trial started and getting the $15M grant. The warrants were issued last year and were going to get exercised anyway. I think Chaim asked them to exercise them now to get the $3M and they decided to sell them to soneone that will. At $1.19 its not a bad deal.
2 · Reply
Mobagri
Mobagri Jun. 25 at 2:07 PM
$BCLI this company is composed of the most inexperienced management team ever. They should have a college course about them in business school.
2 · Reply
thres
thres Jun. 25 at 11:41 AM
$BCLI Many people ask about the funding, we are all worried but nobody can deny Nurown works better than all ALS trials so far. When 100/200 participant get Nurown, some will feel better sooner than others - $$$$? ALS patients recent discussion: "Patient X I just did some research on the company and I wouldn't hold my breath. They have no $$ for the final trial and none of the ALS charities are stepping up. They should do a GoFundMe page, I'll throw in a few hundred $$ to finance the trial. Patient Y So this is not exactly breaking news. It only takes one donor or one investor. Phase 3 wasn't fully funded until it was halfway enrolled last time. I did it anyway. The real issue IMO was when the FDA essentially killed people in September of 2023 when it held that joke of an AdCom for NurOwn, after approving that total joke of a drug the year before. If only we had the current FDA leadership back then..." Let's Make ALS treatable in 1 year not 10. https://alsnewstoday.com/news/9-10-nurown-treated-als-patients-surpass-five-years-survival/
1 · Reply
Righon23420
Righon23420 Jun. 25 at 5:53 AM
$BCLI Could this be acquired? Seems like the best way to get funded but i havent heard this brought up as an option.
1 · Reply
Knuckles30
Knuckles30 Jun. 24 at 9:18 PM
$BCLI Have to believe a bomb is about to go off !! Silence? NDA Shit going on behind the curtains
1 · Reply
fibonacci1170
fibonacci1170 Jun. 24 at 6:08 PM
$BCLI Regardless of all the future dilutions and delays, the upside here is 100-400x if NurOwn hits the primary endpoint. Financially, I got nearly ruined by that fake adcom. But I am happy to throw $2500 (for a potential return of $250,000-$1,000,000) behind NurOwn, and see where the chips land. This could be the biggest comeback in the history of this universe. If that happens, I foresee documentaries and movies made about it in a couple of years time. Better than dying wondering.
2 · Reply
AshvsEvilDead
AshvsEvilDead Jun. 24 at 4:07 PM
$BCLI wow, so will FDA even want or need to rehash an adcomm with Brainstorm? I'm not so sure they would even want to go down that road. We could just see a resubmission on a voucher or simply a resubmission since it already occurred once. What will FDAs appetite be on a type 2 error? This was just shared regarding Capricor.
1 · Reply
thres
thres Jun. 24 at 1:55 PM
$BCLI Willing to try anything? Nurown Endurance Phase 3b trial gives a patient 100% Chances to get 3 shots in 1 year vs 50% chance to get 6 shots. Hard to beat that if you are a prime candidate. Make ALS Treatable in 1 year not 10, let the trial begin and let's see Nurown in action again!!! Coming soon at an Endurance Trial Site Near you.
0 · Reply